Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/27/23 18:30 | 6/27/23 | NOVN | Health | Drug | Pharmaceutical Preparations | Sanders Machelle | NC | D | S | -5 | 0.4082 | 0 | -12 | -31 | 25 | D | |||||||||||||||
6/8/23 21:22 | 6/7/23 | NOVN | Health | Drug | Pharmaceutical Preparations | Gay John M. | NC | O | CFO | M.d | 0 | 0.00 | 0 | 65 | 47 | D | |||||||||||||||
6/8/23 21:22 | 6/7/23 | NOVN | Health | Drug | Pharmaceutical Preparations | Geer W Kent | NC | D | M.d | 0 | 0.00 | 0 | 36 | 999% | 38 | D | |||||||||||||||
6/8/23 21:21 | 6/7/23 | NOVN | Health | Drug | Pharmaceutical Preparations | Sanders Machelle | NC | D | M.d | 0 | 0.00 | 0 | 36 | 999% | 37 | D | |||||||||||||||
6/8/23 21:21 | 6/7/23 | NOVN | Health | Drug | Pharmaceutical Preparations | Bierman James L | NC | D | M.d | 0 | 0.00 | 0 | 36 | 903 | 40 | D | |||||||||||||||
6/8/23 21:21 | 6/7/23 | NOVN | Health | Drug | Pharmaceutical Preparations | Keegan Robert J | NC | D | M.d | 0 | 0.00 | 0 | 36 | 573 | 42 | D | |||||||||||||||
6/8/23 21:21 | 6/7/23 | NOVN | Health | Drug | Pharmaceutical Preparations | Skolsky Steven D | NC | D | M.d | 0 | 0.00 | 0 | 36 | New | 36 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |